Related Experiment Video

Updated: Jul 13, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

The role of cyclooxygenase-2 in breast cancer: review

Gurpreet Singh-Ranger1, Mohamed Salhab, Kefah Mokbel

  • 1St George's University of London, London, UK.

Breast Cancer Research and Treatment
|July 13, 2007
PubMed

Insights

Cyclooxygenase-2 (COX-2) plays a key role in breast cancer development. Nonsteroidal anti-inflammatory drugs (NSAIDs) show moderate benefit, but further research is needed to optimize therapeutic strategies targeting this enzyme.

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Cyclooxygenase-2 (COX-2) is increasingly recognized as a critical factor in breast cancer pathogenesis.
  • COX-2 exerts its effects through both prostaglandin-dependent and independent pathways.

Purpose of the Study:

  • To review the role of COX-2 in breast cancer.
  • To discuss the potential of nonsteroidal anti-inflammatory drugs (NSAIDs) in breast cancer prevention and treatment.
  • To identify areas for future research in manipulating the COX-2 enzyme system for therapeutic benefit.

Main Methods:

  • Review of existing epidemiological studies on NSAID use and breast cancer risk.
  • Analysis of scientific literature on COX-2 expression and its mechanisms in breast cancer.
  • Synthesis of current knowledge on prostaglandin-dependent and independent pathways involved.

Main Results:

  • Epidemiological data indicate a moderate protective effect of NSAIDs against breast cancer.
  • COX-2 expression is a fundamental step in the development of breast cancer.
  • Evidence supports the involvement of both prostaglandin-dependent and independent mechanisms.

Conclusions:

  • COX-2 is a significant therapeutic target in breast cancer.
  • NSAIDs offer a potential, albeit moderate, benefit in breast cancer management.
  • Further investigation is crucial to optimize the clinical application of COX-2 inhibitors for breast cancer therapy.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...